The shareholders in NeuroVive Pharmaceutical AB (publ) reg. no. 556595-6538 (the “Company”) are hereby convened to the extraordinary general meeting, held at 10.00 a.m. on Thursday, 31 March 2016 at Grand Hotel Lund, Bantorget 1 in Lund, Sweden, with admission for registration from 9.30 a.m.
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
“The number of shares shall be not less than 30,000,000 and not more than 120,000,000.”
Entitlement to participate and notification
